BioNTech SE CEO Sahin Ugur sold 20,500 shares at $96.31 each on Sep. 10. He retained 688,209 shares after the transaction, which represented about 2.9% of his prior holding, giving investors a precise measure of the sale against his remaining stake.
Key Highlights
- Sahin Ugur held 688,209 BioNTech SE shares after the transaction.
- The filing identifies transaction code S.
- It reports that he sold 20,500 BioNTech SE shares at $96.31 per share on Sep. 10.
BioNTech SE (NASDAQ: BNTX) Chief Executive Officer Sahin Ugur sold 20,500 shares at $96.31 per share on Sep. 10. Following the transaction, he owned 688,209 shares.
Ugur Retains 688,209 BioNTech Shares
The filing identifies transaction code S. Sahin Ugur is BioNTech SE’s chief executive officer. His reported ownership after the transaction stood at 688,209 shares. The sale involved BioNTech SE shares. The transaction represented about 2.9% of Ugur’s prior shareholding. Transaction code S denotes an open-market or private sale.
FAQs
Q: Why did BioNTech CEO Sahin Ugur sell shares?
A: It reports that he sold 20,500 BioNTech SE shares at $96.31 per share on Sep. 10.
Q: How many BioNTech shares does Sahin Ugur own after the sale?
A: After the transaction, Sahin Ugur owned 688,209 BioNTech SE shares. The filing states that the sale represented about 2.9% of his prior shareholding.
Q: What does the BioNTech CEO share sale mean for investors?
A: The filing reports that Sahin Ugur owned 688,209 shares after the transaction. It also states that the sale represented about 2.9% of his prior holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.